Results 121 to 130 of about 990 (149)

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy. [PDF]

Gynecol Oncol, 2022
Klc TR, Wu S, Wilhite AM, Jones NL, Powell MA, Olawaiye A, Girda E, Brown J, Puechl A, Ali-Fehmi R, Winer IS, Herzog TJ, Korn WM, Erickson BK.   +13 more
europepmc   +1 more source

Cartografia genetica de factores del rendimiento y de caracteres morfologicos, en una poblacion cultivada de cacao criollo "moderno" (Theobroma caaco L.), mediante un analisis de asociacion

, 2007
Las poblaciones no experimentales (naturales o cultivadas) pueden ser empleadas con ciertas ventajas para localizar marcadores moleculares asociados a caracteres de importancia agronómica.
Marcano de Segovia, Maria
core  

A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer. [PDF]

Oncol Rev
Pallatt S, Nambidi S, Adhikary S, Banerjee A, Pathak S, Duttaroy AK.   +5 more
europepmc   +1 more source

Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. [PDF]

World J Clin Cases, 2022
Zhai CY, Yin LX, Han WD.
europepmc   +1 more source

Pancreatitis After Treatment With Encorafenib, Binimetinib, and Cetuximab for BRAF V600E Mutation-Positive Colorectal Cancer. [PDF]

Cureus
Kureyama Y, Hanaoka Y, Tomita D, Matoba S, Kuroyanagi H.   +4 more
europepmc   +1 more source

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment. [PDF]

Front Pharmacol, 2021
Thoma OM, Neurath MF, Waldner MJ.
europepmc   +1 more source

Treatment of biliary tract cancer - essentials for clinical practice. [PDF]

Front Oncol
Liberko M, Soumarova R.
europepmc   +1 more source

Resistance mechanism to pembrolizumab in <i>DEK</i>-<i>AFF2</i> fusion-associated sinonasal squamous cell carcinoma. [PDF]

Int Cancer Conf J
Boku S, Fujisawa T, Kadowaki S, Satake H, Yasui H, Ohtsubo K, Shimizu Y, Otsuka T, Kuze B, Yamashita R, Shibuki T, Nakamura Y, Bando H, Yoshino T, Radovich M, Okano S.   +15 more
europepmc   +1 more source

Decoding the 2023 FIGO Staging System in Endometrial Cancer: A Practical, Visually Guided Framework for Molecular Risk-Adapted Care Incorporating the 2025 Risk Group Update. [PDF]

Curr Oncol Rep
Abacjew-Chmylko A, Razghоnоva Y, Milosz P, Ciarka A, Peksa R, Klasa-Mazurkiewicz D, Wydra DG, Mіka A.   +7 more
europepmc   +1 more source

Peptidomic changes in human serous colorectal cancer patients. [PDF]

J Gastrointest Oncol, 2023
Xu J, Li X, Chen W, Cheng SY, Cheng J, Chen C.   +5 more
europepmc   +1 more source